{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:11:38Z","timestamp":1777551098057,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81601592"],"award-info":[{"award-number":["81601592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81402864"],"award-info":[{"award-number":["81402864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key R&D Program of China","award":["2018YFC1313400"],"award-info":[{"award-number":["2018YFC1313400"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.actbio.2019.07.033","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:27:06Z","timestamp":1563794826000},"page":"461-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor"],"prefix":"10.1016","volume":"97","author":[{"given":"Ling","family":"Che","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanren","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.07.033_b0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2019.07.033_b0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2019.07.033_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1369-7021(05)71033-6","article-title":"Targeted for drug delivery","volume":"8","author":"Fahmy","year":"2005","journal-title":"Mater. Today"},{"key":"10.1016\/j.actbio.2019.07.033_b0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2019.07.033_b0025","doi-asserted-by":"crossref","first-page":"13383","DOI":"10.1039\/C4NR04334K","article-title":"Advances in targeting strategies for nanoparticles in cancer imaging and therapy","volume":"6","author":"Yhee","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2019.07.033_b0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2019.07.033_b0035","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","article-title":"Transcriptional regulation of ABC drug transporters","volume":"22","author":"Scotto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2019.07.033_b0040","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.2174\/1381612822666160617112111","article-title":"Engineered nanoparticles against MDR in cancer: the state of the art and its prospective","volume":"22","author":"Ahmad","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actbio.2019.07.033_b0045","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.addr.2013.09.001","article-title":"Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities","volume":"65","author":"Kirtane","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.07.033_b0050","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1080\/10717544.2017.1410256","article-title":"Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy","volume":"24","author":"Qi","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2019.07.033_b0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2019.07.033_b0060","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1021\/nn405674m","article-title":"Nanoparticles for combination drug therapy","volume":"7","author":"Ma","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2019.07.033_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"\u201cCombo\u201d nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.07.033_b0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biomaterials.2015.09.022","article-title":"Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment","volume":"73","author":"Assanhou","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.07.033_b0075","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2005-07-2819","article-title":"Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib","volume":"106","author":"Kardosh","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2019.07.033_b0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archoto.2011.131","article-title":"The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-kappaB inhibition","volume":"137","author":"Caicedo-Granados","year":"2011","journal-title":"Arch. Otolaryngol.\u2013Head Neck Surg."},{"key":"10.1016\/j.actbio.2019.07.033_b0085","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1593\/neo.12486","article-title":"Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo","volume":"14","author":"Rahman","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.actbio.2019.07.033_b0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7555\/JBR.30.20150108","article-title":"Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion","volume":"30","author":"Whitt","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.actbio.2019.07.033_b0095","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1997.145","article-title":"Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein","volume":"75","author":"Draper","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2019.07.033_b0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00280-005-0162-9","article-title":"Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)","volume":"58","author":"Matsunaga","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.actbio.2019.07.033_b0105","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s11095-008-9596-1","article-title":"Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line","volume":"25","author":"Zrieki","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2019.07.033_b0110","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1021\/acsami.8b22336","article-title":"Facile engineering of indomethacin-induced paclitaxel nanocrystal aggregates as carrier-free nanomedicine with improved synergetic antitumor activity","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2019.07.033_b0115","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1021\/acs.biomac.6b00512","article-title":"Self-assembly of pH-responsive microspheres for intestinal delivery of diverse lipophilic therapeutics","volume":"17","author":"Zhou","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2019.07.033_b0120","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1039\/C5PY00297D","article-title":"A facile route to diverse assemblies by host-guest recognition","volume":"6","author":"Zhou","year":"2015","journal-title":"Polym. Chem-Uk"},{"key":"10.1016\/j.actbio.2019.07.033_b0125","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.actbio.2014.01.024","article-title":"Facile route to versatile nanoplatforms for drug delivery by one-pot self-assembly","volume":"10","author":"Zhou","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.07.033_b0130","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acs.biomac.7b00080","article-title":"A pH-responsive detachable PEG shielding strategy for gene delivery system in cancer therapy","volume":"18","author":"Guan","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2019.07.033_b0135","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41598-017-03111-2","article-title":"Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2019.07.033_b0140","article-title":"Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells. Int","volume":"6","author":"Chen","year":"2011","journal-title":"J Nanomed"},{"key":"10.1016\/j.actbio.2019.07.033_b0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1209\/0295-5075\/19\/3\/001","article-title":"Simulating microscopic hydrodynamic phenomena with dissipative particle dynamics","volume":"19","author":"Hoogerbrugge","year":"1992","journal-title":"Europhys. Lett."},{"key":"10.1016\/j.actbio.2019.07.033_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1209\/0295-5075\/30\/4\/001","article-title":"Statistical mechanics of dissipative particle dynamics","volume":"30","author":"Espa\u00f1ol","year":"1995","journal-title":"Europhys. Lett."},{"key":"10.1016\/j.actbio.2019.07.033_b0155","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1021\/acs.macromol.6b01211","article-title":"pH-Sensitive vesicles formed by amphiphilic grafted copolymers with tunable membrane permeability for drug loading\/release: a multiscale simulation study","volume":"49","author":"Luo","year":"2016","journal-title":"Macromolecules"},{"key":"10.1016\/j.actbio.2019.07.033_b0160","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/nn2000756","article-title":"Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line","volume":"5","author":"Lunov","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2019.07.033_b0165","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.biomaterials.2013.01.030","article-title":"Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids","volume":"34","author":"Mo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.07.033_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090637","article-title":"The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita","volume":"9","author":"Shukla","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2019.07.033_b0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jconrel.2004.12.013","article-title":"Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent","volume":"103","author":"Liu","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.07.033_b0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.07.033_b0185","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.1021\/jp034223y","article-title":"Electrostatic and excluded volume effects on the transport of electrolytes in poly(ethylene glycol)\u2212water \u201cmixed solvents\u201d","volume":"107","author":"Capuano","year":"2003","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.actbio.2019.07.033_b0190","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1039\/C5PY00042D","article-title":"Double pH-responsive supramolecular copolymer micelles based on the complementary multiple hydrogen bonds of nucleobases and acetalated dextran for drug delivery","volume":"6","author":"Kuang","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2019.07.033_b0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2012.06.027","article-title":"pH-sensitive drug loading\/releasing in amphiphilic copolymer PAE-PEG: integrating molecular dynamics and dissipative particle dynamics simulations","volume":"162","author":"Luo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.07.033_b0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0014-5793(02)03710-9","article-title":"PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance","volume":"532","author":"Gbadamosi","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.actbio.2019.07.033_b0205","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/mabi.200800123","article-title":"Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells","volume":"8","author":"Dausend","year":"2008","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2019.07.033_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","article-title":"Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future","volume":"54","author":"Cole","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.actbio.2019.07.033_b0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drup.2012.01.004","article-title":"Starvation, detoxification, and multidrug resistance in cancer therapy","volume":"15","author":"Lee","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.actbio.2019.07.033_b0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00280-008-0920-6","article-title":"Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells","volume":"64","author":"Asano","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.actbio.2019.07.033_b0225","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1042\/bst026s161","article-title":"Effects of indomethacin on mitochondrial ATP synthesis","volume":"26","author":"Jacob","year":"1998","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.actbio.2019.07.033_b0230","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0006-2952(75)90450-5","article-title":"Enterohepatic circulation of indomethacin and its role in intestinal irritation","volume":"24","author":"Duggan","year":"1975","journal-title":"Biochem. Pharmacol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:22:35Z","timestamp":1761672155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119305227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":46,"alternative-id":["S1742706119305227"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.033","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}